Brief: Xbrane Biopharma Q2 EBITDA Loss At Sek 54.8 Million

Xbrane Biopharma AB

13/08/2021 07:40

Aug 13 (Reuters) - Xbrane Biopharma AB  XBRANE.ST :
    * Q2 EBITDA LOSS SEK 54.8 MILLION VERSUS LOSS SEK 51.6
MILLION
YEAR AGO

Source text for Eikon:  ID:nMFN31mlCF 
Further company coverage:  XBRANE.ST 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 772 0920;))